Pharma

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

The board of directors of Medtronic, Inc. approved a 9 percent increase in its cash dividend for fiscal year 2010, raising the quarterly amount to 20.5 cents per share of the company’s common stock, for an annual amount of 82 cents per share. In addition, the board approved an increase in its Share Repurchase Plan, authorizing Medtronic to purchase an additional 60 million shares of its common stock, representing approximately 5.4 percent of the company's total basic shares of common stock outstanding during the quarterly period ending April 2009.


Today in Financial Reports...keeping you current

Ultrasound, nuc med on the upswing
Canadian Healthcare Technology, 10/16/09

Explaining Innovation
PharmExec, 10/16/09

Nabi Biopharmaceuticals Completes Sale of PentaStaph to GlaxoSmithKline PLC
Nabi Biopharmaceuticals, 11/05/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address